Targeted Axillary Dissection Does Benefit Patients with a Single Positive Node Prior to Neoadjuvant Chemotherapy

被引:0
|
作者
Ragunathan, Janani [1 ]
Ledwidge, Serena [2 ]
机构
[1] Queen Mary Univ London, London, England
[2] St Bartholomews Hosp, London, England
关键词
D O I
10.1093/bjs/znad258.211
中图分类号
R61 [外科手术学];
学科分类号
摘要
353
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant Chemotherapy in Node Positive Patients
    Caudle, A. S.
    Yang, W.
    Mittendorf, E. A.
    Black, D. M.
    Gilcrease, M.
    Bedrosian, I.
    Hobbs, B. P.
    Candelaria, R. P.
    Babiera, G.
    Dogan, B. E.
    Lim, M. J.
    Santiago, L.
    Hunt, K. K.
    Krishnamurthy, S.
    Kuerer, H. M.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S6 - S6
  • [2] TARGETED AXILLARY DISSECTION IMPROVES AXILLARY EVALUATION FOLLOWING NEOADJUVANT CHEMOTHERAPY IN NODE POSITIVE PATIENTS
    Caudle, A.
    Yang, W. T.
    Mittendorf, E. A.
    Goravanchi, F.
    Hobbs, B. P.
    Hunt, K. K.
    Lucci, A.
    Krishnamurthy, S.
    Kuerer, H. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 111 - 111
  • [3] Is There Any Advantage of Targeted Axillary Dissection After Neoadjuvant Chemotherapy in Patients with Initially Positive Clipped Node?
    Cabioglu, Neslihan
    Karanlik, Hasan
    Yilmaz, Ravza
    Emiroglu, Selman
    Dursun, Memduh
    Tukenmez, Mustafa
    Kantarci, Tarik Recep
    Yirgin, Inci Kizildag
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Ozmen, Vahit
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S400 - S400
  • [4] Axillary Lymph Node Dissection Should Not Be Avoided in Patients Who Undergo Neoadjuvant Chemotherapy for a Positive Sentinel Node after Targeted Axillary Staging
    Amersi, Farin
    Boyle, Marissa K.
    Rahimtoola, Rhea
    Chung, Alice
    Dang, Catherine
    Karlam, Scott
    Phillips, Edward
    Yuan, Yuan
    Jang, Julie
    Shiao, Stephen L.
    Giuliano, Armando E.
    Tseng, Joshua
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S91 - S91
  • [5] Early Outcomes of Node-Positive Breast Cancer Patients Treated with Targeted Axillary Node Dissection after Neoadjuvant Chemotherapy
    Sun, James
    Carr, Michael
    Sun, Weihong
    Zhou, Junmin
    Kim, Youngchul
    Hoover, Susan J.
    Kiluk, John V.
    Lee, Marie Catherine
    Laronga, Christine
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S267 - S267
  • [6] SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study
    Jennifer L. Baker
    Farnaz Haji
    Amy M. Kusske
    Cheryce P. Fischer
    Anne C. Hoyt
    Carlie K. Thompson
    Minna K. Lee
    Deanna Attai
    Maggie L. DiNome
    Breast Cancer Research and Treatment, 2022, 191 : 107 - 114
  • [7] SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study
    Baker, Jennifer L.
    Haji, Farnaz
    Kusske, Amy M.
    Fischer, Cheryce P.
    Hoyt, Anne C.
    Thompson, Carlie K.
    Lee, Minna K.
    Attai, Deanna
    DiNome, Maggie L.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (01) : 107 - 114
  • [8] Marking Techniques for Targeted Axillary Dissection Among Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy
    Gante, Ines
    Maldonado, Joao Pedro
    Dias, Margarida Figueiredo
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2023, 17
  • [9] Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy
    Balasubramanian, Rajesh
    Morgan, Catrin
    Shaari, Elina
    Kovacs, Tibor
    Pinder, Sarah E.
    Hamed, Hisham
    Sever, Ali R.
    Kothari, Ashutosh
    EJSO, 2020, 46 (06): : 1028 - 1033
  • [10] Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Ludwig, Kandice
    Kong, Amanda L.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (04) : 391 - 397